1. Home
  2. SCLX vs MBBC Comparison

SCLX vs MBBC Comparison

Compare SCLX & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.48

Market Cap

48.5M

Sector

Health Care

ML Signal

HOLD

MBBC

Marathon Bancorp Inc.

N/A

Current Price

$14.50

Market Cap

40.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SCLX
MBBC
Founded
2011
1902
Country
United States
United States
Employees
34
35
Industry
Biotechnology: Pharmaceutical Preparations
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
48.5M
40.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLX
MBBC
Price
$6.48
$14.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
92.4K
15.4K
Earning Date
04-10-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$122.52
N/A
Revenue Next Year
$186.30
N/A
P/E Ratio
N/A
$47.11
Revenue Growth
N/A
N/A
52 Week Low
$4.09
$9.94
52 Week High
$34.27
$15.75

Technical Indicators

Market Signals
Indicator
SCLX
MBBC
Relative Strength Index (RSI) 39.05 50.03
Support Level $6.20 $12.93
Resistance Level $8.18 $15.39
Average True Range (ATR) 1.38 0.60
MACD -0.32 -0.02
Stochastic Oscillator 1.16 23.78

Price Performance

Historical Comparison
SCLX
MBBC

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About MBBC Marathon Bancorp Inc.

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

Share on Social Networks: